Table 2.
Prescribing frequency and frequency of affected patients for each identified PIM
| ATC code | Drug class/name | Prescriptions, n (col %) | Patients, n (col %) 175 |
|---|---|---|---|
| A02 | Drugs for acid-related disorders | 2 (0.9) | 2 (1.1) |
| Aluminium-containing antacids (A02AD01) | 1 (0.4) | 1 (0.6) | |
| Ranitidine (A02BA02) | 1 (0.4) | 1 (0.6) | |
| A03F | Drugs for functional gastrointestinal disorders—propulsives | 3 (1.3) | 3 (1.7) |
| Metoclopramide (A03FA01) | 3 (1.3) | 3 (1.7) | |
| A06A | Laxatives | 19 (8.4) | 19 (10.9) |
| Sodium picosulfate (A06AB08) | 19 (8.4) | 19 (10.9) | |
| A10B | Blood glucose-lowering drugs, excl. insulins | 16 (7.1) | 16 (9.1) |
| Glibenclamide (A10BB01) | 8 (3.5) | 8 (4.6) | |
| Glimepiride (A10BB12) | 1 (0.4) | 1 (0.6) | |
| Glipizide (A10BB07) | 7 (3.1) | 7 (4.0) | |
| B01A | Antithrombotic agents | 6 (2.7) | 6 (3.4) |
| Dabigatran (B01AE07) | 2 (0.9) | 2 (1.1) | |
| Dipyridamole (B01AC07) | 4 (1.8) | 4 (2.3) | |
| C01 | Cardiac therapy | 36 (15.9) | 36 (20.1) |
| Digoxin (C01AA05) | 33 (14.6) | 33 (18.9) | |
| Amiodarone (C01BD01) | 2 (0.9) | 2 (1.1) | |
| Ivabradine (C01EB17) | 1 (0.4) | 1 (0.6) | |
| C02 | Antihypertensives | 4 (1.8) | 4 (2.3) |
| Doxazosin (C02CA04) | 3 (1.3) | 3 (1.7) | |
| Hydralazine (C02DB02) | 1 (0.4) | 1 (0.6) | |
| C03D | Diuretics—potassium-sparing agent | 5 (2.2) | 5 (2.9) |
| Spironolactone (>25 mg/day) (C03DA01) | 5 (2.2) | 5 (2.9) | |
| C07A | Betablocking agents | 3 (1.3) | 3 (1.7) |
| Pindolol (C07AA03) | 2 (0.9) | 2 (1.1) | |
| Propranolol (C07AA05) | 1 (0.4) | 1 (0.6) | |
| C08 | Calcium channel blockers | 4 (1.8) | 4 (2.3) |
| Nifedipine (C08CA05) | 1 (0.4) | 1 (0.6) | |
| Diltiazem (C08DB01) | 2 (0.9) | 2 (1.1) | |
| Verapamil (C08DA01) | 1 (0.4) | 1 (0.6) | |
| G03C | Oestrogens | 6 (2.7) | 6 (3.4) |
| Estriol (oral) (G03CA04) | 6 (2.7) | 6 (3.4) | |
| G04B | Other urologicals, incl. antispasmodics | 12 (5.3) | 12 (6.9) |
| Darifenacin (G04BD10) | 1 (0.4) | 1 (0.6) | |
| Fesoterodin (G04BD11) | 1 (0.4) | 1 (0.6) | |
| Solifenacin (G04BD08) | 6 (2.7) | 6 (3.4) | |
| Tolterodine (G04BD07) | 4 (1.8) | 4 (2.3) | |
| M01A | Anti-inflammatory and antirheumatic products—NSAID (oral) | 3 (1.3) | 3 (1.7) |
| Diclofenac (M01AB05) | 1 (0.4) | 1 (0.6) | |
| Ketoprofen (M01AE03) | 2 (0.9) | 2 (1.1) | |
| M03B | Muscle relaxants—centrally acting agents | 1 (0.4) | 1 (0.6) |
| Orphenadrine (M03BC01) | 1 (0.4) | 1 (0.6) | |
| N02A | Analgesics—opioids | 4 (1.8) | 4 (2.3) |
| Tramadol (N02AX02) | 4 (1.8) | 4 (2.3) | |
| N03A | Antiepileptics | 10 (4.4) | 10 (5.7) |
| Carbamazepine (N03AF01) | 7 (3.1) | 7 (4.0) | |
| Clonazepam (N03AE01) | 2 (0.9) | 2 (1.1) | |
| Phenytoin (N03AB02) | 1 (0.4) | 1 (0.6) | |
| N04 | Antiparkinson drugs | 5 (2.2) | 5 (2.9) |
| Pramipexole (N04BC05) | 3 (1.3) | 3 (1.7) | |
| Trihexyphenidyl (N04AA01) | 2 (0.9) | 2 (1.1) | |
| N05A | Antipsychotics | 7 (3.1) | 7 (4.0) |
| Clozapine (N05AH02) | 1 (0.4) | 1 (0.6) | |
| Haloperidol (>2 mg single dose; >5 mg/day) (N05AD01) | 2 (0.9) | 2 (1.1) | |
| Lithium (N05AN01) | 2 (0.9) | 2 (1.1) | |
| Perphenazine (N05AB03) | 2 (0.9) | 2 (1.1) | |
| N05B | Anxiolytics | 5 (2.2) | 5 (2.9) |
| Alprazolam (N05BA12) | 5 (2.2) | 5 (2.9) | |
| N05C | Hypnotics and sedatives | 57 (25.2) | 57 (32.6) |
| Clomethiazole (N05CM02) | 3 (1.3) | 3 (1.7) | |
| Flunitrazepam (N05CD03) | 2 (0.9) | 2 (1.1) | |
| Nitrazepam (N05CD02) | 1 (0.4) | 1 (0.6) | |
| Propiomazine (N05CM06) | 10 (4.4) | 10 (5.7) | |
| Triazolam (N05CD05) | 1 (0.4) | 1 (0.6) | |
| Zolpideme (>5 mg/day) (N05CF02) | 1 (0.4) | 1 (0.6) | |
| Zopiclone (>3.75 mg/day) (N05CF01) | 39 (17.3) | 39 (22.3) | |
| N06A | Antidepressants | 15 (6.6) | 15 (8.6) |
| Amitryptiline (N06AA09) | 7 (3.1) | 7 (4.0) | |
| Bupropion (N06AX12) | 1 (0.4) | 1 (0.6) | |
| Paroxetine (N06AB05) | 2 (0.9) | 2 (1.1) | |
| Venlafaxine (N06AX16) | 5 (2.2) | 5 (2.9) | |
| R03D | Other systemic drugs for airway diseases | 1 (0.4) | 1 (0.6) |
| Theophylline (R03DA04) | 1 (0.4) | 1 (0.6) | |
| R06A | Antihistamines for systemic use | 2 (0.9) | 2 (1.1) |
| Clemastine (R06AA04) | 2 (0.9) | 2 (1.1) |